Biological Effects of Mesenchymal Stem Cell (MSC) Therapy in Patients With Chronic Lung Allograft Dysfunction (CLAD)

Journal of Heart and Lung Transplantation - Netherlands
doi 10.1016/j.healun.2016.01.438
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Regional Specific Gas Volume as an Early Marker of Chronic Lung Allograft Dysfunction (CLAD)

2016English

Cell-Based Therapy for Chronic Lung Allograft Dysfunction: Patient Selection Remains the Conundrum

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Natural History of Chronic Lung Allograft Dysfunction (CLAD) and Impact of Azithromycin (AZ) in Lung Transplant (LT) Recipients

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2016English

Montelukast in Chronic Lung Allograft Dysfunction After Lung Transplantation

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2019English

Mesenchymal Stem Cell Infusion in Chronic Renal Failure Patients

Journal of Medical and Bioengineering
2015English

Mesenchymal Stem Cell Therapy for Acute and Chronic Pancreatitis

Journal of Gastroenterology
Gastroenterology
2017English

Chronic Renal Allograft Dysfunction: The Role of T Cell-Mediated Tubular Epithelial to Mesenchymal Cell Transition

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2004English

Prediction of Chronic Lung Allograft Dysfunction: A Systems Medicine Challenge

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2014English

Increase of Th17 Cell Phenotype in Kidney Transplant Recipients With Chronic Allograft Dysfunction

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy